We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+12.16%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$11.4B
AUM Growth
+$1.28B
Cap. Flow
+$190M
Cap. Flow %
1.67%
Top 10 Hldgs %
17.01%
Holding
369
New
14
Increased
138
Reduced
152
Closed
7

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$30.3M
2
AAPL icon
Apple
AAPL
+$23.4M
3
MCO icon
Moody's
MCO
+$22.1M
4
MANH icon
Manhattan Associates
MANH
+$20.9M
5
CPK icon
Chesapeake Utilities
CPK
+$18.7M

Sector Composition

Rank Sector Weight
1 Technology 17.69%
2 Healthcare 17.31%
3 Financials 16.14%
4 Industrials 14.89%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIV icon
126
F5
FFIV
$22.1B
$34M 0.3%
237,174
+45,043
+23% +$6.59M
IPG
127
DELISTED
Interpublic Group of Companies
IPG
$33.8M 0.3%
1,015,014
+21,557
+2% +$669K
AFG icon
128
American Financial Group
AFG
$11.8B
$32.8M 0.29%
238,598
+4,953
+2% +$679K
MSM icon
129
MSC Industrial Direct
MSM
$6.78B
$32.3M 0.28%
395,656
-826
-0.2% -$67.4K
AYI icon
130
Acuity Brands
AYI
$10.1B
$32.2M 0.28%
194,180
-743
-0.4% -$132K
TTC icon
131
Toro Company
TTC
$8.72B
$32.1M 0.28%
283,173
+6,572
+2% +$696K
INDB icon
132
Independent Bank
INDB
$4.02B
$31.7M 0.28%
374,909
-1,660
-0.4% -$141K
JKHY icon
133
Jack Henry & Associates
JKHY
$11B
$30.9M 0.27%
175,903
+2,562
+1% +$473K
CRL icon
134
Charles River Laboratories
CRL
$11.3B
$30.6M 0.27%
140,589
+40,316
+40% +$8.8M
IDCC icon
135
InterDigital
IDCC
$7.84B
$30.4M 0.27%
615,013
+71,477
+13% +$3.49M
TRMB icon
136
Trimble
TRMB
$13.3B
$29.5M 0.26%
583,790
-7,692
-1% -$428K
HSY icon
137
Hershey
HSY
$35.9B
$29.3M 0.26%
126,598
+1,650
+1% +$380K
SXT icon
138
Sensient Technologies
SXT
$5.28B
$29.2M 0.26%
399,981
-2,276
-0.6% -$163K
CINF icon
139
Cincinnati Financial
CINF
$26.8B
$28.9M 0.25%
282,046
-440
-0.2% -$45.3K
EVR icon
140
Evercore
EVR
$12.1B
$28.8M 0.25%
263,805
-2,505
-0.9% -$261K
SNA icon
141
Snap-on
SNA
$21.2B
$28.2M 0.25%
123,342
-17,022
-12% -$3.85M
NTAP icon
142
NetApp
NTAP
$34.1B
$27.7M 0.24%
461,695
+25,696
+6% +$1.7M
FWRD icon
143
Forward Air
FWRD
$449M
$27.7M 0.24%
263,865
-1,343
-0.5% -$141K
SSTK icon
144
Shutterstock
SSTK
$198M
$27.6M 0.24%
522,595
-12,426
-2% -$633K
CVX icon
145
Chevron
CVX
$383B
$27.3M 0.24%
151,918
+650
+0.4% +$113K
WSM icon
146
Williams-Sonoma
WSM
$27.5B
$27.2M 0.24%
472,958
+5,192
+1% +$312K
MANH icon
147
Manhattan Associates
MANH
$11.1B
$26.8M 0.24%
220,897
-169,891
-43% -$20.9M
FIX icon
148
Comfort Systems
FIX
$59.8B
$26.7M 0.24%
232,421
-1,594
-0.7% -$185K
BRK.B icon
149
Berkshire Hathaway Class B
BRK.B
$1.1T
$26.7M 0.23%
86,380
-1,415
-2% -$420K
IWM icon
150
iShares Russell 2000 ETF
IWM
$80.2B
$26.1M 0.23%
149,523
+135,132
+939% +$24M

Similar funds

Boston Trust Walden's Q4 2022 Portfolio in Review

As of Q4 2022, Boston Trust Walden held 369 positions worth $11.4B, up 13% from $10.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Trust Walden's Q4 2022 filing shows 14 new, 138 increased, 152 reduced and 7 closed positions. Its largest new stake was BJs Wholesale Club: 726,376 shares worth $48.1M. The largest sale was Medpace, an estimated $30.3M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Boston Trust Walden's largest Q4 2022 buy was BJs Wholesale Club: 726,376 shares worth $48.1M.
  • Boston Trust Walden added most to Littelfuse in Q4 2022, an estimated $25.5M increase.
  • Boston Trust Walden's biggest Q4 2022 reduction was Medpace, cutting an estimated $30.3M.
  • Boston Trust Walden fully exited Chesapeake Utilities in Q4 2022, selling an estimated $18.7M.
  • Boston Trust Walden's ten largest holdings make up 17% of its $11.4B portfolio in Q4 2022.
  • Boston Trust Walden opened 14 new positions and closed 7 in Q4 2022.
  • Boston Trust Walden's portfolio value rose 13% quarter-over-quarter to $11.4B.

Based on Boston Trust Walden's 13F filing for Q4 2022, filed 20 Jan 2023.